« Back
Home /
(-)-DHMEQ

(-)-DHMEQ

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer Bladder Cancer Breast Cancer
Type	Inhibitors
Specific against	other
Amount	5 mg
Item no.	HY-14645-5mg
Targets	NF-κB
CASRN	287194-40-5
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	(-)-DHMEQ (Dehydroxymethylepoxyquinomicin) is a potent, selective and irreversible NF-κB inhibitor that covalently binds to a cysteine residue. (-)-DHMEQ inhibits nuclear translocation of NF-κB and shows anti-inflammatory and anticancer activity[1][2][3].
StorageTemperature	-20°C (Powder, stored under nitrogen)
Shipping	Blue Ice
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	261.23
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cancer; Inflammation/Immunology
Solubility	DMSO : 95 mg/mL (ultrasonic)
Manufacturers Target	NF-κB
Isoform	RelA/p65; RelB
Pathway	NF-κB
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-14645-5mg-safety-datasheet.pdf